IBDEI0TD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13771,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,13771,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,13772,0)
 ;;=N73.9^^53^595^37
 ;;^UTILITY(U,$J,358.3,13772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13772,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,13772,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,13772,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,13773,0)
 ;;=A56.11^^53^595^36
 ;;^UTILITY(U,$J,358.3,13773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13773,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,13773,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,13773,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,13774,0)
 ;;=N73.5^^53^595^64
 ;;^UTILITY(U,$J,358.3,13774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13774,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,13774,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,13774,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,13775,0)
 ;;=N72.^^53^595^35
 ;;^UTILITY(U,$J,358.3,13775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13775,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,13775,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,13775,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,13776,0)
 ;;=N76.3^^53^595^92
 ;;^UTILITY(U,$J,358.3,13776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13776,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,13776,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,13776,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,13777,0)
 ;;=N76.1^^53^595^88
 ;;^UTILITY(U,$J,358.3,13777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13777,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,13777,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,13777,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,13778,0)
 ;;=N76.2^^53^595^91
 ;;^UTILITY(U,$J,358.3,13778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13778,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,13778,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,13778,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,13779,0)
 ;;=N76.0^^53^595^87
 ;;^UTILITY(U,$J,358.3,13779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13779,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,13779,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,13779,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,13780,0)
 ;;=M00.20^^53^595^3
 ;;^UTILITY(U,$J,358.3,13780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13780,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,13780,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,13780,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,13781,0)
 ;;=M00.80^^53^595^4
 ;;^UTILITY(U,$J,358.3,13781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13781,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,13781,1,4,0)
 ;;=4^M00.80
 ;;^UTILITY(U,$J,358.3,13781,2)
 ;;=^5009669
 ;;^UTILITY(U,$J,358.3,13782,0)
 ;;=M00.9^^53^595^72
 ;;^UTILITY(U,$J,358.3,13782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13782,1,3,0)
 ;;=3^Pyogenic Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,13782,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,13782,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,13783,0)
 ;;=M00.00^^53^595^78
 ;;^UTILITY(U,$J,358.3,13783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13783,1,3,0)
 ;;=3^Staphylococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,13783,1,4,0)
 ;;=4^M00.00
 ;;^UTILITY(U,$J,358.3,13783,2)
 ;;=^5009597
 ;;^UTILITY(U,$J,358.3,13784,0)
 ;;=M00.10^^53^595^65
 ;;^UTILITY(U,$J,358.3,13784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13784,1,3,0)
 ;;=3^Pneumococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,13784,1,4,0)
 ;;=4^M00.10
